The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies
Nature Genetics2015Vol. 47(3), pp. 250–256
Citations Over TimeTop 1% of 2015 papers
Luping Lin, Amit J. Sabnis, Elton Chan, Victor Olivas, Lindsay Cade, Evangelos Pazarentzos, Saurabh Asthana, Dana S. Neel, Jenny Yan, Xinyuan Lu, Luu Pham, Mingxue M Wang, Niki Karachaliou, María González Cao, José Luís Zamora Manzano, José Luis Ramírez, J.M. Sanchez Torres, Fiamma Buttitta, Charles M. Rudin, Eric A. Collisson, Alain P. Algazi, Eric M. Robinson, Iman Osman, Eva Muñoz‐Couselo, Javier Cortés, Dennie T. Frederick, Zachary A. Cooper, Martin McMahon, Antonio Marchetti, Rafael Rosell, Keith T. Flaherty, Jennifer A. Wargo, Trever G. Bivona
Related Papers
- → Prediction of effector proteins and their implications in pathogenicity of phytopathogenic filamentous fungi: A review(2022)28 cited
- → Crucial Roles of Effectors in Interactions between Horticultural Crops and Pathogens(2023)7 cited
- → The Hippo–YAP pathway in organ size control and tumorigenesis: an updated version(2010)1,133 cited
- → 20 Effector proteins of bacterial type III protein secretion systems: Elucidating their biochemical effects on eukaryotic signaling cascades(2002)
- → Abstract IA04: Regulation of the Hippo pathway in cancer(2020)